If you're going to use 12ft.io, you should include that link in the body of the post, and keep the original URL as is. As a user browsing their feed, there's no way to tell - prior to clicking - where the link is going to. Masked links are a security/privacy nightmare without any context that lets the user know "This will load content from Scientific American in your browser".
Yeh ffs I hate this kind of prodding by self proclaimed social justice warriors in a context where it has no sense whatsoever. It makes them look stupid, and diminishes the issue in places where it actually is an issue.
Mikklesen response:
"Well, first of all, the film takes place in Denmark in the 1750s. We do have a big plotline about a girl of color who is being subjected to racism, which was very rare, any people of color in Denmark… almost nobody. She was probably at the time the only one in the entire country of Denmark.”"
Diversity shouldn't be a pre-requisite for a story.
It takes place in 2023 New York? Cool, there should be diversity.
It takes place in, say, 1450 Saigon? Diversity would look artificial and out of place.
Ya know, I’ve never thought about that before, but free will is a central theme throughout Christianity. It’s used to explain away all the evil in the world and the story of Adam himself. You could even say it’s a core fundamental belief of the religion.
Trump committed crimes because he didn’t like the outcome of democracy. That gives him a LOT in common with all the totalitarian leaders out there and especially the puppet Presidential structure Russia has.
An advisory panel to the Food and Drug Administration agreed unanimously on Tuesday that a common decongestant ingredient used in many over-the-counter cold medicines is ineffective.
The panel’s vote tees up a likely decision by the agency on whether to essentially ban the ingredient, phenylephrine, which would result in pulling products containing it from store shelves.
If the F.D.A. ordered their removal, a trade group warned that numerous popular products — including Tylenol, Mucinex and Benadryl cold and flu remedies — might become unavailable as companies race to reformulate them.
On Monday and Tuesday, the panel reviewed several existing studies and largely agreed that the research settled the question that the ingredient was useless and no better than a placebo.
Several advisers noted that patients taking the drug were merely delaying their journey to a useful remedy.
“I think we clearly have better options in the over-the-counter space to help our patients, and the studies do not support that this is an effective drug,” said Maria Coyle, the chairwoman of the panel and an associate professor of pharmacy at Ohio State University.
Why It Matters: These Are Popular Staples of the Medicine Cabinet.
Every cold and flu season, millions of Americans reach for these products, some over decades. The decongestant is in at least 250 products that were worth nearly $1.8 billion in sales last year, according to an agency presentation. Among the products: Sudafed Sinus Congestion, Tylenol Cold & Flu Severe, NyQuil Severe Cold & Flu, Theraflu Severe Cold Relief, Mucinex Sinus Max and others.
The ingredient has long been considered safe and effective under an old, outdated agency standard, and the F.D.A. still says that it is safe.
Many remedies that do include phenylephrine also contain other, more effective medicines as well.
And medications that are considered effective for sinus and nasal congestion do still include nasal sprays with phenylephrine, like Afrin, or oral pseudoephedrine, such as Sudafed, or nasal steroids, such as Flonase.
Many popular cold and flu products that don’t specifically target congestion do not include the ingredient.
And it is still widely considered effective when it is used in surgery and to dilate the eyes. It is destroyed in the gut, though, scientists have concluded.
If the agency decides the decongestant should be eliminated from products, it could significantly disrupt the market for the makers of cold medicines if they do not have enough time to replace it in popular items.
What’s more: It could possibly renew widespread use of an alternative, pseudoephedrine, which was placed behind store counters or in locked cabinets because it was often used in illicit meth labs.
Dr. Hendeles, now an emeritus professor, said in an interview on Tuesday that he had been evaluating the ingredient since 1993.
“The bottom line is quality research has told the true story about phenylephrine,” he said.
The F.D.A. has formally now concluded that phenylephrine, when taken orally, is “not effective as a nasal decongestant.”
For consumers, the potential benefits of ending use of the ingredient, the agency suggested, would include avoiding unnecessary costs or delays in care by “taking a drug that has no benefit.”
news
Oldest
This magazine is from a federated server and may be incomplete. Browse more on the original instance.